New Zealand markets closed

Shanghai Junshi Biosciences Co., Ltd. (1877.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
10.740+0.500 (+4.88%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 23.42B
Enterprise value 21.27B
Trailing P/E N/A
Forward P/E 588.24
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.21
Price/book (mrq)1.30
Enterprise value/revenue 14.16
Enterprise value/EBITDA -8.64

Trading information

Stock price history

Beta (5Y monthly) 0.40
52-week change 3-66.64%
S&P500 52-week change 321.08%
52-week high 331.100
52-week low 39.170
50-day moving average 310.975
200-day moving average 317.493

Share statistics

Avg vol (3-month) 31.24M
Avg vol (10-day) 3797.63k
Shares outstanding 5219.3M
Implied shares outstanding 62.29B
Float 8677.4M
% held by insiders 122.43%
% held by institutions 122.93%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -151.97%
Operating margin (ttm)-187.11%

Management effectiveness

Return on assets (ttm)-12.95%
Return on equity (ttm)-29.66%

Income statement

Revenue (ttm)1.5B
Revenue per share (ttm)1.53
Quarterly revenue growth (yoy)119.50%
Gross profit (ttm)N/A
EBITDA -2.22B
Net income avi to common (ttm)-2.28B
Diluted EPS (ttm)-2.510
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.79B
Total cash per share (mrq)3.85
Total debt (mrq)1.79B
Total debt/equity (mrq)24.43%
Current ratio (mrq)2.29
Book value per share (mrq)7.26

Cash flow statement

Operating cash flow (ttm)-2B
Levered free cash flow (ttm)-2.11B